LLS Community

As part of our coverage from the 2017 American Society of Clinical Oncology annual meeting, Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center provides a hopeful update for patients living with MPNs.

Some chemotherapy drugs have been known to affect the peripheral nerves in the nervous system, which can lead to pain, numbness or burning in your limbs, hands or feet - a condition called Chemo Induced Peripheral Neuropathy. If you’re feeling symptoms of neuropathy, talk to your doctor about what you’re experiencing. It’s a frustrating side effect, but if you’re able to be flexible in your treatment schedule, you may be able to reduce your risk by altering the timing of your treat...

August 3, 2017 (Rye Brook, NY) - The Leukemia & Lymphoma Society (LLS) applauds the U.S. Food and Drug Administration (FDA) approval today of CPX-351 (VyxeosTM), an innovative combination of two chemotherapy drugs being used to treat two high-risk subgroups of acute myeloid leukemia (AML) patients. After more than four decades of little progress in treating AML, this approval marks the third drug approval for AML patients in just the past three months. LLS contributed sustained and sign...

Patient advocate Jeff Folloder interviews Dr. John Burke, a CLL expert from Rocky Mountain Cancer Centers to learn Dr. Burke’s perspective on developing research.

Dr. Hearn Jay Cho of Mount Sinai Hospital discusses news out of ASCO 2017 and what it means for myeloma patients.

Host Andrew Schorr catches up with expert Dr. Stephen Ansell, leader of the Lymphoma Group at Mayo Clinic in Rochester, Minnesota, at the 2017 ASCO meeting in Chicago to discuss updates on Hodgkin lymphoma.

At the 2017 ASCO meeting in Chicago, Host Andrew Schorr catches up with expert Dr. Stephen Ansell, leader of the Lymphoma Group at Mayo Clinic in Rochester, Minnesota, to discuss updates for those living with lymphoma.

Summer is in full swing, and many of us are enjoying outdoor activities and lots of time in the sun. For cancer patients, being mindful of sun exposure before, during and after cancer treatment is extremely important. According to The Leukemia & Lymphoma Society’s (LLS) Information Specialists, a team of master’s level oncology social workers, nurses and health educators, sunlight has benefits, but it is important to protect yourself from too much sun exposure. Here is what ...

Today is a very significant day in the progress toward cancer cures. An advisory committee of the U.S. Food & Drug Administration (FDA) unanimously recommended approval of a revolutionary new treatment for patients with relapsed/refractory acute lymphoblastic leukemia (ALL) – an immunotherapy called CAR-T (chimeric antigen receptor T-cell) immunotherapy. The Leukemia & Lymphoma Society recognized the early promise of this new approach, which uses the body’s own immune system to...

Advances in cancer research seem to be occurring at dizzying speed these days. In just the past three years, we’ve seen a plethora of new therapies approved to treat patients with chronic lymphocytic leukemia and multiple myeloma. And the rapidly advancing field of cancer immunotherapy has produced several novel approaches to treat cancer patients by activating their own immune systems to fight the cancer. Meanwhile, as we learn more about the underlying causes of cancer, scientists are ...